These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 16880323

  • 1. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, Sabatine MS.
    Circulation; 2006 Aug 08; 114(6):550-7. PubMed ID: 16880323
    [Abstract] [Full Text] [Related]

  • 2. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, Watanabe T, Nitobe J, Harada M, Suzuki S, Koyama Y, Kitahara T, Sasaki T, Kubota I.
    J Card Fail; 2007 Mar 08; 13(2):120-7. PubMed ID: 17395052
    [Abstract] [Full Text] [Related]

  • 3. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, Barth JH, Hall AS.
    J Am Coll Cardiol; 2010 Jun 08; 55(23):2590-8. PubMed ID: 20513600
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.
    Am J Cardiol; 2009 Jan 01; 103(1):22-8. PubMed ID: 19101224
    [Abstract] [Full Text] [Related]

  • 5. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, Hall AS, EMMACE-2 Investigators.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2061-7. PubMed ID: 18021874
    [Abstract] [Full Text] [Related]

  • 6. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł, Kasprzak JD, Peruga J, Lipiec P, Drozdz J, Krzemińska-Pakuła M, Smigielski J.
    Kardiol Pol; 2008 Mar 20; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [Abstract] [Full Text] [Related]

  • 7. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.
    J Intern Med; 2007 Dec 20; 262(6):651-8. PubMed ID: 17986200
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):357-64. PubMed ID: 19608034
    [Abstract] [Full Text] [Related]

  • 9. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.
    Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088
    [Abstract] [Full Text] [Related]

  • 10. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
    Kaczyñska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P.
    Clin Chim Acta; 2006 Sep 15; 371(1-2):117-23. PubMed ID: 16698008
    [Abstract] [Full Text] [Related]

  • 11. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł, Wraga M, Bednarkiewicz Z, Lipiec P, Smigielski J, Krzemińska-Pakuła M, Kasprzak JD.
    Kardiol Pol; 2011 Sep 15; 69(1):1-6. PubMed ID: 21267954
    [Abstract] [Full Text] [Related]

  • 12. [Diagnostic and prognostic value of heart-type fatty acid-binding protein (H-FABP), an early biochemical marker of myocardial injury].
    Bertinchant JP, Polge A.
    Arch Mal Coeur Vaiss; 2005 Dec 15; 98(12):1225-31. PubMed ID: 16435602
    [Abstract] [Full Text] [Related]

  • 13. Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure.
    Niizeki T, Takeishi Y, Arimoto T, Okuyama H, Takabatake N, Tachibana H, Nozaki N, Hirono O, Tsunoda Y, Miyashita T, Fukui A, Takahashi H, Koyama Y, Shishido T, Kubota I.
    J Cardiol; 2005 Jul 15; 46(1):9-15. PubMed ID: 16095226
    [Abstract] [Full Text] [Related]

  • 14. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D, Seeberger MD, Lurati Buse GA, Christen P, Rupinski B, Gürke L, Filipovic M.
    Anesth Analg; 2009 Apr 15; 108(4):1069-75. PubMed ID: 19299763
    [Abstract] [Full Text] [Related]

  • 15. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
    Januzzi JL, Newby LK, Murphy SA, Pieper K, Antman EM, Morrow DA, Sabatine MS, Ohman EM, Cannon CP, Braunwald E.
    Am Heart J; 2006 Feb 15; 151(2):360-6. PubMed ID: 16442899
    [Abstract] [Full Text] [Related]

  • 16. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K, Sasaki T, Hanatani A, Kim J, Hashimura K, Ishida Y, Ohkaru Y, Asayama K, Tanaka T, Ogai A, Nakatani T, Kitamura S, Kangawa K, Miyatake K, Kitakaze M.
    Heart; 2006 May 15; 92(5):615-8. PubMed ID: 16387818
    [Abstract] [Full Text] [Related]

  • 17. Heart fatty acid-binding protein in combination with the 80-lead body surface potential map improves early detection of acute myocardial infarction in patients who are cardiac troponin T-negative at presentation.
    Daly MJ, McCann CJ, Owens CG, Harbinson MT, Adgey JA.
    J Electrocardiol; 2011 May 15; 44(4):432-8. PubMed ID: 21529821
    [Abstract] [Full Text] [Related]

  • 18. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN, Tsiaousis GZ, Georgilas AT, Makrygiannis SS, Adamopoulou EN, Handanis SM, Batika PC, Prekates AA, Velissaris D, Kouris NT, Mytas DZ, Babalis DK, Karidis KS, Foussas SG.
    Int J Cardiol; 2010 Jun 11; 141(3):284-90. PubMed ID: 19157603
    [Abstract] [Full Text] [Related]

  • 19. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K.
    Circulation; 2009 Jun 30; 119(25):3181-8. PubMed ID: 19528340
    [Abstract] [Full Text] [Related]

  • 20. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction.
    Haltern G, Peiniger S, Bufe A, Reiss G, Gülker H, Scheffold T.
    Am J Cardiol; 2010 Jan 01; 105(1):1-9. PubMed ID: 20102882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.